HollisterStier-Draxis

HollisterStier Contract Manufacturing and sister organization, Draxis Pharma, have appointed Steven Rowan as vice president of business development, Jubilant Organosys Contract Manufacturing North America. Mr. Rowan will oversee a HollisterStier-Draxis corporate business development team.

The two companies have a partnership joining their capabilities and services under the ownership of Jubilant Organosys. Mr. Rowan will be responsible for global business development activities for HollisterStier and Draxis, as well as establishing strategic partnerships to strengthen the companies’ presence throughout Europe and Asia.

Mr. Rowan has more than 20 years of experience in the pharmaceutical and biopharmaceutical industries. His in-depth knowledge, extensive scientific background and experience implementing Six Sigma methodologies will benefit the organizations as they align their manufacturing services.

“I look forward to being a part of this team as we transition into having a more heightened global presence,” said Mr. Rowan. “Together, we offer a level of technical expertise, multiple dosage forms, and understanding of the entire life cycle that proves to be very competitive in the outsourcing industry ─ this is an exciting opportunity for me to help showcase our competitive advantages and strategically position HollisterStier and Draxis Pharma as leading industry players.”